SCHEMBL15664326

SCHEMBL15664326

O=C1CCN(C(=O)O)c2ccc(C(F)(F)F)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.51
ATM Q13315 1/20 0.45
LMNA P02545 2/20 0.42
RAB9A P51151 1/20 0.42
CNR2 P34972 1/20 0.41
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
SRD5A1 P18405 2/20 0.39
SRD5A2 P31213 2/20 0.39
PARP1 P09874 1/20 0.38
PARP10 Q53GL7 1/20 0.38
MAPT P10636 3/20 0.38
KDR P35968 1/20 0.38
SRPK2 P78362 1/20 0.38
SRPK1 Q96SB4 1/20 0.38
SRPK3 Q9UPE1 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15663537 0.82 NOTUM (0.48) NOTUMATMSRD5A1SRD5A2MAPT
SCHEMBL30681440 0.81 NOTUM (0.76) NOTUMLMNACNR2HTR2AHTR2C
SCHEMBL15663577 0.81 NOTUM (0.48) NOTUMLMNARAB9ACNR2SRD5A1
SCHEMBL6754157 0.80 PDK1 (0.42) NOTUMLMNARAB9ASRD5A1SRD5A2
SCHEMBL23705411 0.78 LMNA (0.45) LMNARAB9ASRD5A1SRD5A2MEN1
SCHEMBL2530222 0.78 CNR2 (0.62) NOTUMLMNACNR2HTR2AHTR2C
SCHEMBL28041701 0.77 NOTUM (0.48) NOTUMATMLMNASRD5A1SRD5A2
SCHEMBL1451477 0.76 NOTUM (0.64) NOTUMLMNACNR2CES2TSHR
SCHEMBL3530939 0.76 NOTUM (0.44) NOTUMMAPTKDRSRPK2SRPK1
SCHEMBL7552151 0.75 NOTUM (0.63) NOTUMLMNARAB9AHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662185-B2 Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-05-26 US disclosed
US-20190248783-A9 AMINO-SUBSTITUTED IMIDAZO[1,2-A] PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-08-15 US disclosed
US-20180319794-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A] PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-11-08 US disclosed
US-10052312-B2 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-08-21 US disclosed
US-20170182014-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-06-29 US disclosed
US-9624214-B2 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-04-18 US disclosed
US-20150274719-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-10-01 US disclosed
US-9126998-B2 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use Bayer Pharma AG (DE) 2015-09-08 US disclosed
US-20140179672-A1 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-06-26 US disclosed
US-20140128372-A1 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140128372-A1 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use AADAC, TNNI3, PAICS NOTUM 2034/4885ATM 2466/4885LMNA 252/4885
US-20140179672-A1 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use AADAC, TNNI3, PAICS NOTUM 2034/4885ATM 2466/4885LMNA 252/4885
US-10052312-B2 Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use AADAC, TNNI3, PAICS NOTUM 2034/4885ATM 2466/4885LMNA 252/4885
US-20190248783-A9 AMINO-SUBSTITUTED IMIDAZO[1,2-A] PYRIDINECARBOXAMIDES AND THEIR USE AADAC, TNNI3, PAICS NOTUM 2034/4885ATM 2466/4885LMNA 252/4885
US-10662185-B2 Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use AADAC, TNNI3, TNNT2 NOTUM 1883/4885ATM 2487/4885LMNA 330/4885
US-20150274719-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AADAC, TNNI3, PAICS NOTUM 2034/4885ATM 2466/4885LMNA 252/4885
US-20180319794-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A] PYRIDINECARBOXAMIDES AND THEIR USE AADAC, TNNI3, PAICS NOTUM 2034/4885ATM 2466/4885LMNA 252/4885
US-20170182014-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AADAC, TNNI3, PAICS NOTUM 2034/4885ATM 2466/4885LMNA 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.